Tianjin Medical University General Hospital

This study tests whether roxadustat, a drug currently used to treat anemia in kidney disease, can also slow or reverse muscle loss (sarcopenia) in people on hemodialysis. About 60 adults with end-stage kidney disease and anemia will receive either roxadustat or standard erythropo…

This study tests whether giving a large amount of IV saline (about 2-2.5 liters) right after clot-busting treatment helps people recover from a stroke better than giving only a small amount. The trial will enroll 752 adults aged 18-80 who had an ischemic stroke and received throm…

This study tests whether using a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), is safe for treating early-stage non-small cell lung cancer. About 50 adults with multiple lung nodules will receive TILs therapy. The main goal is to check for side effects…

This early-phase study tests whether combining a patient's own tumor-fighting immune cells (TILs) with a newer targeted drug can be safe for people with advanced lung cancer that no longer responds to standard targeted therapy. About 50 adults aged 18-75 with EGFR-mutant non-smal…

This study tests if a painkiller called oliceridine can prevent long-term pain after lung surgery better than the usual drug, sufentanil. About 320 adults having keyhole lung surgery will receive one of the two drugs through a pump they control. The main goal is to see if fewer p…

This study tests whether a single injection of esketamine given during a C-section can lessen severe itching in women with intrahepatic cholestasis of pregnancy, a liver condition that causes intense itch. About 160 women will be randomly assigned to receive either esketamine or …